Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.890
-0.200 (-9.57%)
At close: Aug 7, 2026, 4:00 PM EDT
1.830
-0.060 (-3.17%)
After-hours: Aug 7, 2026, 7:59 PM EDT

ZYBT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9055----
Market Cap Growth
-65.32%-----
Enterprise Value
92.8965.940000
Last Close Price
1.891.15----
PS Ratio
5.313.28----
PB Ratio
2.771.53----
P/TBV Ratio
0.460.28----
P/FCF Ratio
48.3930.94----
P/OCF Ratio
44.7328.60----
EV/Sales Ratio
5.513.96----
EV/FCF Ratio
50.2037.43----
Debt / Equity Ratio
0.240.240.220.260.180.09
Debt / EBITDA Ratio
--2.131.300.770.44
Debt / FCF Ratio
6.096.093.152.20-2.35
Net Debt / Equity Ratio
0.090.090.230.270.190.09
Net Debt / EBITDA Ratio
-0.52-0.521.641.070.650.35
Net Debt / FCF Ratio
1.881.882.421.80-5.521.86
Asset Turnover
0.250.250.380.420.540.48
Inventory Turnover
1.901.901.631.662.272.03
Quick Ratio
0.580.580.780.770.950.86
Current Ratio
1.141.141.311.261.411.31
Return on Equity (ROE)
-25.17%-25.17%3.89%10.78%16.50%14.57%
Return on Assets (ROA)
-17.51%-17.51%3.10%7.56%11.90%10.30%
Return on Invested Capital (ROIC)
-24.67%-21.74%3.70%9.35%15.22%13.39%
Return on Capital Employed (ROCE)
-20.94%-20.94%4.65%12.55%19.16%16.39%
FCF Yield
2.07%3.23%----
Payout Ratio
-0.00%141.66%125.42%45.84%23.78%
Buyback Yield / Dilution
-3.69%-3.69%0.00%0.00%0.00%-
Total Shareholder Return
-3.69%-3.69%0.00%0.00%0.00%-
SEC Filings: 10-K · 10-Q